Altogether, these results suggest reversal of the IP3R dysfunction in F508del-CFTR epithelial cells by a pharmacological correction of the abnormal trafficking of F508del-CFTR in cystic fibrosis cells. The gene discussed is CFTR; the disease is cystic fibrosis.